Identifying BRCA (BReast CAncer) gene pathogenic variants at point of diagnosis can help optimise breast cancer treatment, especially for patients who might exhibit aggressive disease. Understanding when to test is critical to support treatment and disease management. Let’s empower informed and shared decision-making in breast cancer care. #BreastCancer
Axcelerant
5d
Identifying BRCA gene variants at diagnosis is a game-changer. It’s like having a roadmap that helps guide treatment decisions and improve outcomes, particularly for those facing more aggressive forms of the disease.
Parabéns pela vossa preocupação dos tratamentos do Cacer da mama. Sempre em evolução.
Possibility of personalized treatment with BRCA gene testing
Early testing not only guides treatment but also opens the door to more personalized and effective management strategies.